All Monoclonal Antibodies
- 2 mins to read
Treating cluster headache remains one of the most formidable challenges in neurology, necessitating a rigorous search for new preventive options. In a study published in Cephalalgia, titled “Efficacy and effectiveness of anti-CGRP monoclonal antibodies treatment in the prevention of cluster headache attacks: A systematic review and meta-analysis,” Kolakowski and colleagues investigated the performance of monoclonal antibodies targeting the CGRP pathway in both episodic and chronic forms of the condition.
Join the Community
Subscribe to receive updates on new research findings, articles and inspired conversations.
We respect your privacy. Unsubscribe at any time.